NHS National Pharmaceuticals - Everolimus and terminated agreement products

Tender Close: 26th April, 13:00.

Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement products

Offer reference number: CM/PHG/21/5632

Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Potential periods of call-offs under the framework agreement:

Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022

Oral Products: All regions: to commence as soon as possible with an end date of 28/02/2022

Hospital Only Products: DLS, DNE, DNW, DLN and DSW regions: to commence as soon as possible with an end date 31/01/2022

Tender Documents

• Opportunity notice on Contracts Finder → — Tender notice
• Document No. 00 - Read Me First Document - Everolimus → — Link
• Document No. 07a - Quality control technical sheet → — Link
• Document No. 01 - Invitation to offer covering letter → — Link
• Document No. 02 - Terms of offer → — Link
• Document No. 05a (v) Product Listing & Usage - Hospital Only Products CM_PHG_21_5632_02 → — Link
• Document No. 05b - Selectt offer schedule instructions → — Link
• Document No. 03 - Framework Agreement and Terms and Conditions → — Link
• Document No. 04 - Contract technical specification → — Link
• Document No. 05a (ii), 05a (iv), 05a (vi) CM_PHG_21_5632 SELECTT Application → — Link
• Document No. 05a (i) Product Listing & Usage - Everolimus CM_PHG_21_5632_00 → — Link
• Document No. 05a (iii) Product Listing & Usage - Oral (plus non-parenteral) products CM_PHG_21_5632_01 → — Link
• Document No. 08 - Confidential information schedule → — Link
• FTS Notice - NHS National Pharmaceuticals - Everolimus and terminated agreement products → — Link
• Document No. 06 - Form of offer → — Link